State-Level Variation in GLP-1 Receptor Agonist Use Among Medicaid Beneficiaries Without Diabetes by State Obesity Coverage Policy

Chen Dun, Michael Fang, Dan Wang, Gary Hettinger, Morgan E. Grams, Caitlin W. Hicks, Elizabeth Selvin, Mariana P. Socal, Jung-Im Shin

Open source

DOI
10.2337/dc26-1511
Published
2026-08-24
Container
Diabetes Care
Publisher
American Diabetes Association
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2337/dc26-1511,
  title = {State-Level Variation in GLP-1 Receptor Agonist Use Among Medicaid Beneficiaries Without Diabetes by State Obesity Coverage Policy},
  author = {Chen Dun and Michael Fang and Dan Wang and Gary Hettinger and Morgan E. Grams and Caitlin W. Hicks and Elizabeth Selvin and Mariana P. Socal and Jung-Im Shin},
  year = {2026},
  journal = {Diabetes Care},
  doi = {10.2337/dc26-1511},
  url = {https://doi.org/10.2337/dc26-1511}
}

RIS

TY  - JOUR
TI  - State-Level Variation in GLP-1 Receptor Agonist Use Among Medicaid Beneficiaries Without Diabetes by State Obesity Coverage Policy
AU  - Chen Dun
AU  - Michael Fang
AU  - Dan Wang
AU  - Gary Hettinger
AU  - Morgan E. Grams
AU  - Caitlin W. Hicks
AU  - Elizabeth Selvin
AU  - Mariana P. Socal
AU  - Jung-Im Shin
PY  - 2026
JO  - Diabetes Care
DO  - 10.2337/dc26-1511
UR  - https://doi.org/10.2337/dc26-1511
ER  - 

APA

Dun, C., Fang, M., Wang, D., Hettinger, G., Grams, M. E., Hicks, C. W., Selvin, E., Socal, M. P., & Shin, J. (2026). State-Level Variation in GLP-1 Receptor Agonist Use Among Medicaid Beneficiaries Without Diabetes by State Obesity Coverage Policy. Diabetes Care. https://doi.org/10.2337/dc26-1511

Source records